title: Recombinant human erythropoietin enhances superoxide production by FMLP-stimulated polymorphonuclear leukocytes in hemodialysis patients.
abstract: Recombinant human erythropoietin (rHuEPO) is a hematopoietic growth factor that has a broad spectrum of action. We have observed the in vivo and in vitro effects of rHuEPO on the superoxide production of circulating polymorphonuclear leukocytes (PMNs) in hemodialysis patients. The PMNs were separated from heparinized blood after dextran sedimentation and Ficoll-Conray centrifugation and stimulated with formyl-methionyl-leucyl-phenylalanine (FMLP), serum-treated zymosan (STZ), or phorbol myristate acetate (PMA). The in vivo study showed that rHuEPO therapy for 12 weeks enhanced the superoxide production by FMLP-stimulated PMNs (P < 0.01). However, no significant changes on superoxide production was found in either STZ- or PMA-stimulated PMNs. Simultaneous measurement of PGE2 production by PMNs in response to all three stimulants did not show any significant changes after rHuEPO therapy. The direct in vitro effect of rHuEPO on PMNs showed that rHuEPO does not enhance the superoxide production by non-stimulated PMNs. However, preincubation of rHuEPO enhanced superoxide production from FMLP- and STZ-stimulated PMNs. Our results indicate that rHuEPO enhanced FMLP-stimulated superoxide production of PMNs both in vivo and in vitro in hemodialysis patients, which may be responsible for the increased oxidant stress in hemodialysis patients after rHuEPO therapy.
authors.affiliation: Department of Internal Medicine, Kaohsiung Medical College, Taiwan, Republic of China.
authors.forename: H C
authors.initials: HC
authors.lastname: Chen
authors.forename: J C
authors.initials: JC
authors.lastname: Tsai
authors.forename: J H
authors.initials: JH
authors.lastname: Tsai
authors.forename: Y H
authors.initials: YH
authors.lastname: Lai
mesh_terms: D000328:Adult; D000368:Aged; D015232:Dinoprostone / Q000096:biosynthesis; D004305:Dose-Response Relationship, Drug; D004921:Erythropoietin / Q000494:pharmacology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000494:pharmacology*; D009504:Neutrophils / Q000187:drug effects* / Q000378:metabolism; D011994:Recombinant Proteins; D006435:Renal Dialysis; D013481:Superoxides / Q000378:metabolism*
chemical_list: D011994:Recombinant Proteins; D013481:Superoxides; D004921:Erythropoietin; D009240:N-Formylmethionine Leucyl-Phenylalanine; D015232:Dinoprostone